Septum Pellucidum

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 1131 Experts worldwide ranked by ideXlab platform

Alissa Old Crow - One of the best experts on this subject based on the ideXlab platform.

Ahmed Gilani - One of the best experts on this subject based on the ideXlab platform.

Erik H Middlebrooks - One of the best experts on this subject based on the ideXlab platform.

Peter P Sun - One of the best experts on this subject based on the ideXlab platform.

  • myxoid glioneuronal tumor pdgfra p k385 mutant clinical radiologic and histopathologic features
    Brain Pathology, 2020
    Co-Authors: Calixtohope G Lucas, Mitchel S Berger, Javier Villanuevameyer, Nicholas S Whipple, Nancy Ann Oberheim Bush, Tabitha Cooney, Susan M Chang, Michael W Mcdermott, Elaine Cham, Peter P Sun
    Abstract:

    "Myxoid glioneuronal tumor, PDGFRA p.K385-mutant" is a recently described tumor entity of the central nervous system with a predilection for origin in the Septum Pellucidum and a defining dinucleotide mutation at codon 385 of the PDGFRA oncogene replacing lysine with either leucine or isoleucine (p.K385L/I). Clinical outcomes and optimal treatment for this new tumor entity have yet to be defined. Here, we report a comprehensive clinical, radiologic, and histopathologic assessment of eight cases. In addition to its stereotypic location in the Septum Pellucidum, we identify that this tumor can also occur in the corpus callosum and periventricular white matter of the lateral ventricle. Tumors centered in the Septum Pellucidum uniformly were associated with obstructive hydrocephalus, whereas tumors centered in the corpus callosum and periventricular white matter did not demonstrate hydrocephalus. While multiple patients were found to have ventricular dissemination or local recurrence/progression, all patients in this series remain alive at last clinical follow-up despite only biopsy or subtotal resection without adjuvant therapy in most cases. Our study further supports "myxoid glioneuronal tumor, PDGFRA p.K385-mutant" as a distinct CNS tumor entity and expands the spectrum of clinicopathologic and radiologic features of this neoplasm.

Goncalves P Pereira - One of the best experts on this subject based on the ideXlab platform.

  • two dimensional visualization and measurement of the fetal optic chiasm improving counseling for antenatal diagnosis of agenesis of the Septum Pellucidum
    Ultrasound in Obstetrics & Gynecology, 2016
    Co-Authors: F Vinals, Pilar Ruiz, F Correa, Goncalves P Pereira
    Abstract:

    Objective To develop an objective method for visualizing and measuring the fetal optic chiasm (OC) using transvaginal two-dimensional (2D) ultrasound in the coronal plane and to report measurements in fetuses with agenesis of the Septum Pellucidum (SP). Methods This was a prospective cross-sectional study of 115 morphologically normal fetuses in low-risk pregnancies, between 21 and 30 weeks' gestation. The OC was measured in a coronal plane at the level of the third ventricle and was seen as a horizontally aligned dumbbell-shaped structure of moderate echogenicity. In addition, OC measurements from eight fetuses with agenesis of the SP and complete follow-up were compared with the reference range. Results OC measurements were obtained in 110/115 normal fetuses and showed that OC increases linearly with gestational age. Our method of measurement demonstrated good intraobserver repeatability and excellent interobserver reproducibility. Among the eight fetuses with agenesis of the SP, five had normal OC measurements and five had normal vision postnatally. Pregnancy continued to term in all cases and the follow-up period varied from 6 months to 7 years. Conclusion Our study demonstrates that it is possible to visualize and measure the OC directly on a 2D ultrasound coronal plane. In fetuses with agenesis of the SP, the morphology and width of the OC visual pathway could prove a relevant tool for assessing its development. It would also help in the difficult task of providing antenatal counseling when faced with the diagnosis of agenesis of the SP. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.